Watson Pharmaceuticals recalls Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manu

Recalled February 13, 2013 · FDA recall D-145-2013 · Watson Pharmaceuticals

Hazard

Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%). · FDA Class II

Units

3,040 bottles

Sold at

Nationwide and Puerto Rico

Description

Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).

Product

Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.

Manufacturer(s)

Watson Pharmaceuticals

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →